Evidence map›Paper›PMID 32251271›Full record

ArticleTranslational psychiatry2020

Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action.

Amit Anand, Kunio Nakamura, Jeffrey M Spielberg, Jungwon Cha, Harish Karne, Bo Hu

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2023
    Article
  14. Review
  15. RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amit AnandCenter for Behavioral Health, Cleveland Clinic, Cleveland, OH, USA. ananda@ccf.org.
Kunio NakamuraDepartment of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA.
Jeffrey M SpielbergDepartment of Psychiatry, University of Delaware, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-8348-7157
Jungwon ChaCenter for Behavioral Health, Cleveland Clinic, Cleveland, OH, USA.
Harish KarneCenter for Behavioral Health, Cleveland Clinic, Cleveland, OH, USA.
Bo HuCenter for Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · USUniversity of Delaware · US

Funding

Dysfunctional Cortico-Limbic Activity and Connectivity in Bipolar Disorder and LiR01MH075025 · NIMH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ANAND, AMIT · 2007 to 2010
$1.8M
NIMH NIH HHS R01 MH075025U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01 MH075025-03S2
6 · The paper itself

Abstract

Lithium is a highly effective medication for bipolar disorder, but its mechanism of action remains unknown. In this study, brain MRI scans and blood samples for gene expression (total of 110 scans and 109 blood samples) were collected from 21 bipolar subjects before and after 2 and 8 weeks of lithium monotherapy and at the same time-points from untreated 16 healthy controls. We used linear mixed-effects models to identify brain structural features and genes with expression changed after lithium treatment, with correction for multiple testing, and correlated their concurrent changes to identify molecular pathways associated with lithium effects. There are significant increases in gray matter fraction, global cortical thickness, and the frontal and parietal cortices after 8 weeks of lithium treatment (corrected p < 0.05). Volume increases were also seen for putamen, hippocampus, thalamic nuclei, and thalamic substructures. Several genes showed significant expression changes, and 14 gene pathways were identified for the present integration analysis. Of these, nine pathways had significant correlations with structural changes (FDR < 0.05). Three neurotrophy-related pathways (GDNF family of ligands, NFAT immune-response, and p53-signaling pathway) correlated with structural changes in multiple regions. Mediation analysis showed that the sphingomyelin metabolism pathway is associated with HAM-D change (p < 0.01), and this effect is mediated via the volume of mediodorsal thalamus (p < 0.03). In summary, the integration of lithium effects on brain structural and peripheral gene expression changes revealed effects on several neurotrophic molecular pathways, which provides further insights into the mechanism of lithium action.

Indexed as

Bipolar DisorderLithiumAntimanic AgentsBrainGene ExpressionHumansMagnetic Resonance ImagingAntimanic AgentsLithium

Identifiers

PMID32251271
PMCPMC7136209
OpenAlexW3015186099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.